Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Avidity Biosciences (RNA) EPS (Weighted Average and Diluted): 2020-2024

Historic EPS (Weighted Average and Diluted) for Avidity Biosciences (RNA) over the last 5 years, with Dec 2024 value amounting to -$2.89.

  • Avidity Biosciences' EPS (Weighted Average and Diluted) fell 95.38% to -$1.27 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.19, marking a year-over-year decrease of 44.98%. This contributed to the annual value of -$2.89 for FY2024, which is 0.69% up from last year.
  • Per Avidity Biosciences' latest filing, its EPS (Weighted Average and Diluted) stood at -$2.89 for FY2024, which was up 0.69% from -$2.91 recorded in FY2023.
  • In the past 5 years, Avidity Biosciences' EPS (Weighted Average and Diluted) registered a high of -$2.05 during FY2020, and its lowest value of -$3.34 during FY2022.
  • For the 3-year period, Avidity Biosciences' EPS (Weighted Average and Diluted) averaged around -$3.05, with its median value being -$2.91 (2023).
  • Per our database at Business Quant, Avidity Biosciences' EPS (Weighted Average and Diluted) slumped by 39.02% in 2021 and then rose by 12.87% in 2023.
  • Yearly analysis of 5 years shows Avidity Biosciences' EPS (Weighted Average and Diluted) stood at -$2.05 in 2020, then plummeted by 39.02% to -$2.85 in 2021, then dropped by 17.19% to -$3.34 in 2022, then rose by 12.87% to -$2.91 in 2023, then climbed by 0.69% to -$2.89 in 2024.